[SCHEDULE 13G/A] Prenetics Global Ltd Amended Passive Investment Disclosure
Genetel, Michael Yang report 3.3% stake in Prenetics
Prenetics Global Ltd ownership update: Genetel Bioventures Ltd and Michael Yang Mengsu report beneficial ownership of 488,857 Class A Ordinary Shares, representing 3.3% of the Class A shares outstanding.
Prenetics Global Ltd ownership update: Genetel Bioventures Ltd and Michael Yang Mengsu report beneficial ownership of 488,857 Class A Ordinary Shares, representing 3.3% of the Class A shares outstanding. The percentage is calculated on an aggregate of 14,697,463 Class A Ordinary Shares outstanding as of March 31, 2026.
The statement is filed by Genetel and Mr. Yang Mengsu and clarifies voting and dispositive powers shown on the cover page. Signatures on the amendment are dated April 22, 2025.
Positive
None.
Negative
None.
Key Figures
Shares beneficially owned:488,857 sharesPercent of class:3.3%Shares outstanding:14,697,463 shares+3 more
6 metrics
Shares beneficially owned488,857 sharesReported beneficial ownership by Genetel and Michael Yang
Percent of class3.3%Percent of Class A outstanding as of March 31, 2026
Shares outstanding14,697,463 sharesClass A Ordinary Shares outstanding as of March 31, 2026
CUSIPG72245122Identifier for Class A Ordinary Shares
Signature date04/22/2025Date signed by reporting persons
Key Terms
Schedule 13G/A, beneficially owned, sole dispositive power, shares outstanding
4 terms
Schedule 13G/Aregulatory
"Amendment No. 2 ) Prenetics Global Ltd Class A Ordinary Shares"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially ownedfinancial
"Amount beneficially owned: The information required by Item 4(a)"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive powerfinancial
"Sole Dispositive Power 488,857.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
shares outstandingmarket
"aggregate of 14,697,463 Class A Ordinary Shares outstanding as of March 31, 2026"
Shares outstanding are the total number of a company’s stock units held by all shareholders, including institutional investors and company insiders — think of them as the total number of slices of the company’s ownership pie. Investors use this number to calculate how much of the company each share represents, and it directly affects per-share measures like earnings per share, ownership percentage and valuation; when the slice count changes, an investor’s claim and the company’s per-share metrics change too.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Genetel Bioventures hold in Prenetics Global (PRE)?
Genetel Bioventures reports beneficial ownership of 488,857 Class A Ordinary Shares. This equals 3.3% of the Class A shares outstanding based on 14,697,463 shares as of March 31, 2026.
Does Michael Yang Mengsu directly own shares of PRE?
Yes. Michael Yang Mengsu is reported as a reporting person with beneficial ownership of 488,857 Class A Ordinary Shares, representing 3.3% of the Class A outstanding as of March 31, 2026.
What date is used to calculate the ownership percentage for PRE?
The ownership percentage is calculated using the aggregate number of Class A Ordinary Shares outstanding: 14,697,463 shares as of March 31, 2026, per the filing's stated reference.
Who filed the Schedule 13G/A for PRE and where are they located?
The filing was made by Genetel Bioventures Limited (a Hong Kong private company) and Michael Yang Mengsu. Their business address is given in Hong Kong at 7B Yardley Commercial Building, 3 Connaught Road West.
What voting or dispositive powers are reported for the PRE shares?
The cover-page rows show 488,857 shares with sole voting power and sole dispositive power for the reporting persons. The filing incorporates those cover-page figures by reference.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
Prenetics Global Ltd
(Name of Issuer)
Class A Ordinary Shares, par value $0.0015 per share
(Title of Class of Securities)
G72245122
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
G72245122
1
Names of Reporting Persons
Genetel Bioventures Ltd
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
HONG KONG
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
488,857.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
488,857.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
488,857.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.3 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
G72245122
1
Names of Reporting Persons
Michael Yang Mengsu
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CHINA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
488,857.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
488,857.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
488,857.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.3 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Prenetics Global Ltd
(b)
Address of issuer's principal executive offices:
Unit 703-706, K11 Atelier King's Road 728 King's Road, Quarry Bay, Hong Kong.
Item 2.
(a)
Name of person filing:
This statement is filed by:
(i) Genetel Bioventures Limited ("Genetel"), a Hong Kong private limited company; and
(ii) Michael Yang Mengsu ("Mr. Yang Mengsu"), the controlling shareholder of Genetel.
The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."
The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Securities Exchange Act of 1934, the beneficial owner of the securities reported herein.
(b)
Address or principal business office or, if none, residence:
The address of the business office of each of the Reporting Persons is 7B Yardley Commercial Building, 3 Connaught Road West, Sheung Wan, Hong Kong.
(c)
Citizenship:
Genetel is a Hong Kong private limited company. Mr. Yang Mengsu is a citizen of China (Hong Kong SAR).
(d)
Title of class of securities:
Class A Ordinary Shares, par value $0.0015 per share
(e)
CUSIP No.:
G72245122
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
The percentage set forth in this Schedule 13G is calculated based upon an aggregate of 14,697,463 Class A Ordinary Shares outstanding as of March 31, 2026, as reported in the Company's Registration Statement on Form F-3 filed with the Securities and Exchange Commission on March 31, 2026.
(b)
Percent of class:
3.3%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(ii) Shared power to vote or to direct the vote:
The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iii) Sole power to dispose or to direct the disposition of:
The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iv) Shared power to dispose or to direct the disposition of:
The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
See Item 2(a).
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Genetel Bioventures Ltd
Signature:
/s/ George William Hunter Cautherley
Name/Title:
By: Genetel Bioventures Ltd., By: George William Hunter Cautherley, Director
